How It Works? 
How It's Given? 
Common Side Effects 
Community To Join 
Clinical Trials 
Recommended Videos Treatment for active multiple myeloma for transplant candidates depends on how far the cancer has spread, biomarker test results, and overall health. For you or your loved one, whether this is a first diagnosis or the cancer has come back, compare FDA-approved options side by side below, then review them with the care team.
Loading Your Options...
See If A Clinical Trial Is Right For You or Your Loved One
It is important to learn about clinical trials for your cancer type, their potential benefits, and risks, and then discuss all of your options with your doctors.
Answering a few questions in the Search Tool below will help you find relevant trials by Study Phase: Phase 1, Phase 2, or Phase 3 or by Study Type: Interventional or Observational.
Mobile users, please “X out” or “Accept All Cookies” to begin your search.
Understanding Clinical Trials
Is A Clinical Trial Right For You?
Informed Consent Protects Your Rights
What To Expect When You Participate
Active Multiple Myeloma for Transplant Candidates Treatment Videos
Understanding Myeloma Treatment Types
What are the types of treatment available for myeloma?
What Are the Phases of Myeloma Treatment?
Myeloma specialist Dr. Mark Schroeder explains the phases of myeloma treatment, defining induction, consolidation, and maintenance therapy for patients with myeloma.
Multiple Myeloma: Symptoms, Treatment, and Patient Care
Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell.
Most Frequently Asked Questions
What are the treatment options for active multiple myeloma for transplant candidates?
Treatment for active multiple myeloma for transplant candidates depends on how far the cancer has spread, biomarker test results, and overall health. The comparison below lists options side by side. The care team can explain which ones fit.
Why does biomarker testing matter for active multiple myeloma for transplant candidates?
For active multiple myeloma for transplant candidates, biomarker results can help doctors plan treatment. The test looks at a sample of tissue or blood for genes, proteins, or other molecules linked to cancer. See the biomarker guide.
Can treatment change if active multiple myeloma for transplant candidates comes back or stops working?
It can. For returning active multiple myeloma for transplant candidates, the treatment may match the first plan or change. Doctors repeat tests to find where the cancer is and how far it has spread.
Should I get a second opinion before treating active multiple myeloma for transplant candidates?
Before treating active multiple myeloma for transplant candidates, many people ask a second specialist to review the plan. This is a common, normal step. Find a top cancer hospital.
